Stockscreener 앱 받기
2.68
5.32%
-0.14
Nexalin Technology Inc 주식(NXL)의 최신 뉴스
Nexalin Technology CEO Mark White Issues Letter to - GlobeNewswire
Nexalin Technology CEO sends letter to shareholders - TipRanks
Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025 - The Manila Times
Nexalin's Revolutionary DIFS Technology Shows 65% Success Rate in Depression Treatment - StockTitan
Certain Common Stock of Nexalin Technology, Inc. are subject to a Lock-Up Agreement Ending on 2-JAN-2025. - Marketscreener.com
Certain Options of Nexalin Technology, Inc. are subject to a Lock-Up Agreement Ending on 2-JAN-2025. - Marketscreener.com
Nexalin Technology (NASDAQ:NXL) Shares Up 5.5% – Here’s What Happened - Defense World
How Do Things Look For Nexalin Technology Inc (NASDAQ: NXL) In The Short-Term? - Stocks Register
Nexalin Technology, Inc. Launches Phase 1 of AI-Driven Virtual Clinic to Enhance Mental Health Treatment - Nasdaq
Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic - GlobeNewswire
Nexalin Technology, Inc. Completes Phase 1 of Its Innovative Virtual Clinic - Marketscreener.com
Target Corp (TGT-N) QuotePress Release - The Globe and Mail
Walmart Inc (WMT-N) QuotePress Release - The Globe and Mail
Maxim Group Reaffirms Hold Rating for Nexalin Technology (NASDAQ:NXL) - Defense World
Nexalin Technology’s Strong Financial Position: No Defaults on Senior Securities - MSN
Nexalin Technology downgraded to Hold from Buy at Maxim - MSN
Maxim Group Downgrades Nexalin Technology (NXL) - MSN
Nexalin Technology Stock Soars to All-Time High of $4.4 Amidst Stunning Growth - Investing.com Canada
Nexalin Technology (NASDAQ:NXL) and ENDRA Life Sciences (NASDAQ:NDRA) Head-To-Head Survey - Defense World
Nexalin Technology, Inc. (NASDAQ:NXL) Short Interest Update - MarketBeat
New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market - Marketscreener.com
Nexalin Technology announces peer-reviewed publication on DIFS technology - Nasdaq
New Peer-Reviewed Publication Validates Nexalin’s Deep - GlobeNewswire
Nexalin's Brain Stimulation Tech Breakthrough Validated in Major Medical Journal | NXL Stock News - StockTitan
Alibaba Group Holding ADR (BABA-N) QuotePress Release - The Globe and Mail
Nexalin Technology stock soars to all-time high of $4.07 - Investing.com
Nexalin Technology stock soars to all-time high of $4.07 By Investing.com - Investing.com UK
Nexalin Technology CEO Provides Letter to Shareholders - GlobeNewswire
Nexalin's Breakthrough: Alzheimer's Studies Show Promise, Secures Key Brain Tech Patent | NXL Stock News - StockTitan
Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 ResultsCERo Therapeutics Hldgs (NASDAQ:CERO) - Benzinga
Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Invest In Growth? - Yahoo Finance
Nexalin Technology Inc (NXL) Quarterly 10-Q Report - Quartzy
Nexalin regains Nasdaq compliance with bid price rule By Investing.com - Investing.com Australia
Nexalin regains Nasdaq compliance with bid price rule - Investing.com India
Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on November 5th - The Manila Times
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th - GlobeNewswire
Nexalin Technology : Regains Compliance with Nasdaq Continued Listing Requirements Form 8 K - Marketscreener.com
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements - The Manila Times
LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
Nexalin technology's chief medical officer buys $1,095 in stock By Investing.com - Investing.com Canada
Nexalin technology's chief medical officer buys $1,095 in stock - Investing.com India
Significant Stock Increase For Nexalin (NXL) After Alzheimer’s Study Announcement - Stocks Telegraph
EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients - AOL
0.78%
0.02%
자본화:
|
볼륨(24시간):